[go: up one dir, main page]

Ullah et al., 2019 - Google Patents

Use of Tumor Targeting Bacteria as Cancer Therapeutic Agents and Drug Delivery Vehicles: A Conceptual Approach

Ullah et al., 2019

View PDF
Document ID
15871432241699639029
Author
Ullah N
et al.
Publication year
Publication venue
EC Microbiol

External Links

Snippet

Cancer is an uncontrolled and non-regulated cell proliferation disorder. It remains a life- threatening disease around the globe. Unavailability of effective cancer treatment causes hundreds of thousands deaths every year throughout the world. More effective and less …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)

Similar Documents

Publication Publication Date Title
Wei et al. Bacterial targeted tumour therapy-dawn of a new era
Sedighi et al. Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities
Staedtke et al. Clostridium novyi-NT in cancer therapy
Patyar et al. Bacteria in cancer therapy: a novel experimental strategy
Zhou et al. Tumour-targeting bacteria engineered to fight cancer
Weerakkody et al. The role of bacterial toxins and spores in cancer therapy
US9598697B2 (en) Recombinant bacterium to decrease tumor growth
Ryan et al. Use of bacteria in anti‐cancer therapies
US9198950B2 (en) Recombinant bacterium comprising a toxin/antitoxin system
Lemmon et al. Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment
Theys et al. Tumor-specific gene delivery using genetically engineered bacteria
Chorobik et al. Salmonella and cancer: from pathogens to therapeutics
Sarotra et al. Use of bacteria in cancer therapy
Barbé et al. The use of clostridial spores for cancer treatment
Kubiak et al. The potential of clostridial spores as therapeutic delivery vehicles in tumour therapy
Dosoky et al. Engineering the gut microbiota to treat chronic diseases
Staedtke et al. Hypoxia-targeting bacteria in cancer therapy
KR102683896B1 (en) Expression Vector for Secreting GM-CSF and Anticancer Recombinant Microbials Transformed thereby
Lu et al. Bacteria-based nanoprobes for cancer therapy
Ullah Use of Tumor Targeting Bacteria as Cancer Therapeutic Agents and Drug Delivery Vehicles: A Conceptual Approach
Bermudes et al. Tumour-selective Salmonella-based cancer therapy
CN116478895B (en) Recombinant Salmonella typhimurium genetically engineered strain HCS1, bacterial agents and their applications
Sabzehali et al. Bacteria as a vehicle in cancer therapy and drug delivery
Wang et al. Bacteriolytic therapy with Clostridium ghonii for experimental solid tumors
CN114522184B (en) Cell lysate of engineering bacteria and application thereof in tumor treatment